AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Rosuvastatin & Ezetimibe in South Africa
4 products registered with SAHPRA — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ROSUZET 20 mg/10 mg | 55/7.5/0226 | Cipla Medpro (Pty) Ltd | active | 22 Nov 2027 |
| ROSUZET 40 mg/10 mg | 55/7.5/0227 | Cipla Medpro (Pty) Ltd | active | 22 Nov 2027 |
| ROSUZET 5 mg/10 mg | 55/7.5/0224 | Cipla Medpro (Pty) Ltd | active | 22 Nov 2027 |
| ROSUZET 10 mg/10 mg | 55/7.5/0225 | Cipla Medpro (Pty) Ltd | active | 22 Nov 2027 |
Rosuvastatin & Ezetimibe — SAHPRA Registration Details
SAHPRA (South Africa) has 4 registered products containing Rosuvastatin & Ezetimibe, of which 4 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Rosuvastatin & Ezetimibe registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.